Annual Drug Patent Expirations for GOPRELTO
Goprelto is a drug marketed by Genus Lifesciences and is included in one NDA. There are six patents protecting this drug.
Drug patent litigation for GOPRELTO.
The generic ingredient in GOPRELTO is cocaine hydrochloride. Additional details are available on the cocaine hydrochloride profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
